CURE’s mesothelioma page is a go-to resource for oncology news and updates in the world of mesothelioma Here, readers will find cancer articles, videos, podcasts, and more with expert insight to the latest treatments and research in mesothelioma.
November 26th 2021
Part B of the DIONE-01 study will look at whether IOA-244 increases anti-tumor responses in expansion groups of patients.
November 16th 2021
Imfinzi plus platinum-pemetrexed chemotherapy induced survival improvements in patients with previously untreated, unresectable malignant pleural mesothelioma, compared with chemotherapy alone.
October 26th 2021
Treatment with the immunotherapy Opdivo for relapsed, malignant mesothelioma may represent a useful choice for patients with minimal therapy options.
September 20th 2021
The average survival for patients with malignant pleural mesothelioma was less than a month after being diagnosed with COVID-19, according to a small study.
August 26th 2021
Surgery for malignant pleural mesothelioma after radiotherapy may increase overall survival rates, according to a study. However, study authors note that the procedure should only be adopted in centers with substantial surgical experience.
April 12th 2021
Mesothelioma has been categorized as an “older persons” disease, writes a 14-year survivor. Which is why, she writes, her and her family were completely caught off-guard when she was diagnosed at 21.
October 20th 2020
The FDA’s approval or Opdivo (nivolumab) and Yervoy (ipilimumab) for the frontline treatment of patients with unresectable malignant pleural mesothelioma was desperately needed, says a thoracic oncologist at Memorial Sloan Kettering Cancer center. However, some questions remain.
October 2nd 2020
The Food and Drug Administration’s approval of Opdivo in combination with Yervoy for patients with unresectable malignant pleural mesothelioma marks the first new systemic therapy approved in more than 15 years in this setting.
November 25th 2019
Here is a list of clinical trials that are currently happening within the mesothelioma space.
November 22nd 2019
From plans to sue the School District of Philadelphia over a mesothelioma diagnosis to Dwayne “The Rock” Johnson singing for a 3-year-old with acute lymphoblastic leukemia, here’s what is making headlines in the cancer space this week.
October 19th 2019
The same properties that make certain cancers hard to treat may also promote their death by ferroptosis, scientists at the Sloan Kettering Institute have found.
October 11th 2019
A seven-year mesothelioma survivor encourages patients with cancer to be their own advocate.
October 11th 2019
A phase 3 trial compared Keytruda versus chemotherapy for patients with advanced pretreated malignant pleural mesothelioma.
September 20th 2019
Cediranib combined with platinum-based chemotherapy helped patients live longer than placebo.
August 12th 2019
A registered dietician discussed the importance of maintaining one’s weight while going through treatment for mesothelioma.
July 29th 2019
CURE® spoke with one expert about the various treatment options and current clinical trials available to patients with mesothelioma, as well as what they have to look forward to in the future.
July 26th 2019
CURE spoke with one expert about mesothelioma symptoms that patients can be on the lookout for, as well as how to be knowledgeable about certain risk factors.
June 19th 2019
Routine use of prophylactic radiotherapy in patients with malignant pleural mesothelioma is unnecessary following a chest wall procedure, according to multicenter, open-label, phase 3, randomized controlled trial findings published in the Journal of Clinical Oncology.
June 18th 2019
Results from a clinical trial in people with mesothelioma indicate that an experimental chimeric antigen receptor-T cell therapy is safe and may provide benefit to patients, especially in combination with other immunotherapies.
June 18th 2019
Maintenance therapy with defactinib failed to improve survival following front-line chemotherapy in patients with merlin-low malignant pleural mesothelioma, according to results from the phase 2 COMMAND trial.
May 24th 2019
The Food and Drug Administration has approved the NovoTTF-100L System in combination with pemetrexed and platinum-based chemotherapy for the front-line treatment of patients with unresectable, locally advanced or metastatic malignant pleural mesothelioma.
June 22nd 2018
An immunotherapy pair looks promising for those with pleural mesothelioma, which is now treated with chemotherapy.
November 10th 2017
Clinical trials of combination immunotherapy treatments are showing impressive overall survival rates.
April 5th 2017
After a shocking diagnosis, Heather Von St. James is on a mission to spread awareness about mesothelioma.
November 19th 2015
Immune checkpoint inhibitors have demonstrated encouraging results for patients with small cell lung cancer (SCLC) and mesothelioma, two aggressive thoracic malignancies with few options.
June 4th 2015
An ambitious clinical trial set to start in July will match patients to treatments based on molecular abnormalities, rather than cancer types, testing 20 targeted drugs at once.
November 24th 2014
Finding specialized care is worth the effort for patients with uncommon cancers.
March 16th 2007
Readers respond to past CURE articles on living with mesothelioma, hospice, beating bladder cancer, lung cancer, and response to CURE's 2007 Cancer Resource Guide.